documents: FDA-2009-D-0095-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2009-D-0095-0002 | FDA | FDA-2009-D-0095 | Clinical Pharmacology Section of Labeling for Human Prescription Drug and Biological Products--Content and Format - Draft Guidance | Other | Guidance | 2009-03-04T05:00:00Z | 2009 | 3 | 2009-03-04T05:00:00Z | 2024-11-07T22:03:36Z | 1 | 0 | 09000064808e9a43 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref